- Home
- FLX vs ARCT Comparison
FLX vs ARCT Comparison
Compare FLX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLX
- ARCT
- Stock Information
- Founded
- FLX 2013
- ARCT 2013
- Country
- FLX China
- ARCT United States
- Employees
- FLX N/A
- ARCT N/A
- Industry
- FLX
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- FLX
- ARCT Health Care
- Exchange
- FLX NYSE
- ARCT Nasdaq
- Market Cap
- FLX N/A
- ARCT 298.3M
- IPO Year
- FLX 2024
- ARCT N/A
- Fundamental
- Price
- FLX $3.25
- ARCT $13.10
- Analyst Decision
- FLX
- ARCT Strong Buy
- Analyst Count
- FLX 0
- ARCT 8
- Target Price
- FLX N/A
- ARCT $52.33
- AVG Volume (30 Days)
- FLX 105.9K
- ARCT 494.3K
- Earning Date
- FLX 05-22-2025
- ARCT 08-04-2025
- Dividend Yield
- FLX N/A
- ARCT N/A
- EPS Growth
- FLX N/A
- ARCT N/A
- EPS
- FLX N/A
- ARCT N/A
- Revenue
- FLX $595,490,250.00
- ARCT $143,680,000.00
- Revenue This Year
- FLX N/A
- ARCT N/A
- Revenue Next Year
- FLX N/A
- ARCT $34.79
- P/E Ratio
- FLX N/A
- ARCT N/A
- Revenue Growth
- FLX N/A
- ARCT 15.38
- 52 Week Low
- FLX $2.01
- ARCT $8.04
- 52 Week High
- FLX $21.95
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- FLX N/A
- ARCT 51.41
- Support Level
- FLX N/A
- ARCT $12.03
- Resistance Level
- FLX N/A
- ARCT $14.58
- Average True Range (ATR)
- FLX 0.00
- ARCT 0.91
- MACD
- FLX 0.00
- ARCT 0.03
- Stochastic Oscillator
- FLX 0.00
- ARCT 32.66
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.